Aspire Biopharma enters LOI to acquire Dura Driver Control Systems for $30M

Aspire Biopharma (ASBP) Holdings entered into a Letter of Intent to acquire Dura Driver Control Systems, a designer and manufacturer of automotive driver control systems that also apply to other industrial applications. Management of DCS will be bolstered by the addition of a team from Lakewood & Company with more than 100 years’ collective experience within the automotive industry. The company said, “The proposed acquisition represents a transformative milestone for Aspire and positions the Company to grow into a diversified, high-revenue enterprise. DCS delivered more than $20M in Adjusted EBITDA on $200M+ Revenue for FY2025. DCS provides a technical proprietary portfolio of over 275 different parts and 310 patents serving more than 150 vehicle platforms across most major automotive OEMs. Lakewood and existing management bring over 200 years of collective automotive experience with major OEMs, Suppliers, and related Industrial Companies.” Subject to completion of due diligence, including completion and review of an audit of DCS’s financial statements under U.S. GAAP, Aspire is expected to acquire 100% of DCS for a total purchase price of $30M paid in cash.